Anticoagulation in AF Following PCI: Guideline Updates and Real-World Evidence

Published: 06 November 2020

  • Views:

    Views Icon 44

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

This programme focuses upon recent data related to use of oral anticoagulants in AF patients following PCI, as well as updates to the ESC Guidelines for clinical practice.

This discussion was funded by an unrestricted educational service from Boehringer Ingelheim

Learning Objectives

  • Summarise the Recent Updates to the European Society of Cardiology Atrial Fibrillation Guidelines
  • State the Clinical Studies That Have Influenced the Recent Guideline Updates
  • Recall the Different Study Designs Used in Pivotal Clinical Trials Assessing NOAC Use Post-PCI

More from this programme

Part 1

Managing AF Following PCI: Interpreting ESC Guideline Updates

1 session
Managing AF Following PCI: Interpreting ESC Guideline Updates Watch now

Part 2

Real World Outcomes in AF Patients Undergoing PCI

1 session
Real World Outcomes in AF Patients Undergoing PCI Watch now

Faculty Biographies

Leonardo De Luca

Leonardo De Luca

Ospedale San Camillo-Forlanini, Rome, IT

View full profile
Jan Steffel

Jan Steffel

Prof Jan Steffel is Vice Chairman of the Department of Cardiology at the University Heart Center, at the University of Zurich. He trained in invasive electrophysiology and devices in Lausanne, Boston, and Munich. Prof Steffel has authored or co-authored over one hundred articles.

View full profile